TransMedics shareholders approve director elections, equity plan amendment increasing share reserve to 5.39M shares

TransMedics Group, Inc.

All eight director nominees elected; advisory say-on-pay approved with 22.9M for, 1.16M against.
Amendment to 2019 Stock Incentive Plan approved: share reserve increased to 5,390,502 shares (includes 2,640,502 outstanding awards).
Plan term extended to June 1, 2036; new grants on/after Jan 1, 2027 subject to minimum one-year vesting (5% carve-out).
PricewaterhouseCoopers ratified as independent auditor for FY 2026 with 28.0M votes for.

item 5.07 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-234440
form_type: 8-K
ticker: TMDX
cik: 0001756262
company_name: TransMedics Group, Inc.
filed_at: 2026-05-21T20:15:24+00:00
discovered_at: 2026-05-21T20:17:00.353051+00:00
generated_at: 2026-05-21T22:06:04.513537+00:00
sec_items: ["5.07", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-234440
json_url: https://secwatch.observer/filing/0001193125-26-234440.json
markdown_url: https://secwatch.observer/filing/0001193125-26-234440.md
text_url: https://secwatch.observer/filing/0001193125-26-234440.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1756262/000119312526234440/0001193125-26-234440-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1756262/000119312526234440/d79022d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

SYRE

Spyre Therapeutics stockholders approve amended ESPP; director Peter Harwin resigns

Spyre Therapeutics, Inc. May 29, 2026, 4:45 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

FFAI

Faraday Future signs 23-unit robot order, first healthcare delivery; annual meeting passed with 80% support

FARADAY FUTURE INTELLIGENT ELECTRIC INC. May 29, 2026, 4:15 PM ET other_material Items 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

ACDC

ProFrac shareholders elect all six director nominees, approve say-on-pay

ProFrac Holding Corp. June 1, 2026, 4:02 PM ET other_material Items 5.07

same SEC item: 5.07 same event type: other_material similar materiality

Filing page SEC filing

KROS

Keros CEO to present at Goldman Sachs healthcare conference June 8

Keros Therapeutics, Inc. June 1, 2026, 4:02 PM ET other_material Items 7.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

HNVR

Shareholders elect three directors, approve equity plan, ratify auditor at annual meeting

Hanover Bancorp, Inc. /MD June 1, 2026, 4:00 PM ET other_material Items 5.02, 5.07

same SEC item: 5.07 same event type: other_material similar materiality

Filing page SEC filing

US Alliance Corp

US Alliance Corp stockholders re-elect all five directors and ratify Crowe LLP at annual meeting

US Alliance Corp June 1, 2026, 3:28 PM ET other_material Items 5.07

same SEC item: 5.07 same event type: other_material similar materiality

Filing page SEC filing

REGENCY CENTERS LP

Regency Centers releases updated investor presentation for conferences

REGENCY CENTERS LP June 1, 2026, 3:24 PM ET other_material Items 7.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

WORLDS INC

Worlds Inc. changes name to Gemaxel Inc., effective March 26, 2026

WORLDS INC June 1, 2026, 2:59 PM ET other_material Items 5.03, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001193125-26-234440

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.